Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study

Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We determined the prevalence, correlates and outcomes associated with frailty among adults admitted to intensive care. We prospectively enrolled 421 crit...

Full description

Saved in:
Bibliographic Details
Published in:Canadian Medical Association journal (CMAJ) Vol. 186; no. 2; pp. E95 - E102
Main Authors: Bagshaw, Sean M., Stelfox, H. Thomas, McDermid, Robert C., Rolfson, Darryl B., Tsuyuki, Ross T., Baig, Nadia, Artiuch, Barbara, Ibrahim, Quazi, Stollery, Daniel E., Rokosh, Ella, Majumdar, Sumit R.
Format: Journal Article
Language:English
Published: Canada Joule Inc 04.02.2014
CMA Impact, Inc
Canadian Medical Association
Subjects:
ISSN:0820-3946, 1488-2329, 1488-2329
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We determined the prevalence, correlates and outcomes associated with frailty among adults admitted to intensive care. We prospectively enrolled 421 critically ill adults aged 50 or more at 6 hospitals across the province of Alberta. The primary exposure was frailty, defined by a score greater than 4 on the Clinical Frailty Scale. The primary outcome measure was in-hospital mortality. Secondary outcome measures included adverse events, 1-year mortality and quality of life. The prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more comorbidities and greater functional dependence than those who were not frail. In-hospital mortality was higher among frail patients than among non-frail patients (32% v. 16%; adjusted odds ratio [OR] 1.81, 95% CI 1.09-3.01) and remained higher at 1 year (48% v. 25%; adjusted hazard ratio 1.82, 95% CI 1.28-2.60). Major adverse events were more common among frail patients (39% v. 29%; OR 1.54, 95% CI 1.01-2.37). Compared with nonfrail survivors, frail survivors were more likely to become functionally dependent (71% v. 52%; OR 2.25, 95% CI 1.03-4.89), had significantly lower quality of life and were more often readmitted to hospital (56% v. 39%; OR 1.98, 95% CI 1.22-3.23) in the 12 months following enrolment. Frailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and mortality. Diagnosis of frailty could improve prognostication and identify a vulnerable population that might benefit from follow-up and intervention.
AbstractList Interpretation: Frailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and mortality. Diagnosis of frailty could improve prognostication and identify a vulnerable population that might benefit from follow-up and intervention.
Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We determined the prevalence, correlates and outcomes associated with frailty among adults admitted to intensive care.BACKGROUNDFrailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We determined the prevalence, correlates and outcomes associated with frailty among adults admitted to intensive care.We prospectively enrolled 421 critically ill adults aged 50 or more at 6 hospitals across the province of Alberta. The primary exposure was frailty, defined by a score greater than 4 on the Clinical Frailty Scale. The primary outcome measure was in-hospital mortality. Secondary outcome measures included adverse events, 1-year mortality and quality of life.METHODSWe prospectively enrolled 421 critically ill adults aged 50 or more at 6 hospitals across the province of Alberta. The primary exposure was frailty, defined by a score greater than 4 on the Clinical Frailty Scale. The primary outcome measure was in-hospital mortality. Secondary outcome measures included adverse events, 1-year mortality and quality of life.The prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more comorbidities and greater functional dependence than those who were not frail. In-hospital mortality was higher among frail patients than among non-frail patients (32% v. 16%; adjusted odds ratio [OR] 1.81, 95% CI 1.09-3.01) and remained higher at 1 year (48% v. 25%; adjusted hazard ratio 1.82, 95% CI 1.28-2.60). Major adverse events were more common among frail patients (39% v. 29%; OR 1.54, 95% CI 1.01-2.37). Compared with nonfrail survivors, frail survivors were more likely to become functionally dependent (71% v. 52%; OR 2.25, 95% CI 1.03-4.89), had significantly lower quality of life and were more often readmitted to hospital (56% v. 39%; OR 1.98, 95% CI 1.22-3.23) in the 12 months following enrolment.RESULTSThe prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more comorbidities and greater functional dependence than those who were not frail. In-hospital mortality was higher among frail patients than among non-frail patients (32% v. 16%; adjusted odds ratio [OR] 1.81, 95% CI 1.09-3.01) and remained higher at 1 year (48% v. 25%; adjusted hazard ratio 1.82, 95% CI 1.28-2.60). Major adverse events were more common among frail patients (39% v. 29%; OR 1.54, 95% CI 1.01-2.37). Compared with nonfrail survivors, frail survivors were more likely to become functionally dependent (71% v. 52%; OR 2.25, 95% CI 1.03-4.89), had significantly lower quality of life and were more often readmitted to hospital (56% v. 39%; OR 1.98, 95% CI 1.22-3.23) in the 12 months following enrolment.Frailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and mortality. Diagnosis of frailty could improve prognostication and identify a vulnerable population that might benefit from follow-up and intervention.INTERPRETATIONFrailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and mortality. Diagnosis of frailty could improve prognostication and identify a vulnerable population that might benefit from follow-up and intervention.
Background: Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We determined the prevalence, correlates and outcomes associated with frailty among adults admitted to intensive care. Methods: We prospectively enrolled 421 critically ill adults aged 50 or more at 6 hospitals across the province of Alberta. The primary exposure was frailty, defined by a score greater than 4 on the Clinical Frailty Scale. The primary outcome measure was in-hospital mortality. Secondary outcome measures included adverse events, 1-year mortality and quality of life. Results: The prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more comorbidities and greater functional dependence than those who were not frail. In-hospital mortality was higher among frail patients than among nonfrail patients (32% v. 16%; adjusted odds ratio [OR] 1.81, 95% CI 1.09-3.01) and remained higher at 1 year (48% v. 25%; adjusted hazard ratio 1.82, 95% CI 1.28-2.60). Major adverse events were more common among frail patients (39% v. 29%; OR 1.54, 95% CI 1.012.37). Compared with nonfrail survivors, frail survivors were more likely to become functionally dependent (71% v. 52%; OR 2.25, 95% CI 1.03-4.89), had significantly lower quality of life and were more often readmitted to hospital (56% v. 39%; OR 1.98, 95% CI 1.22-3.23) in the 12 months following enrolment. Interpretation: Frailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and mortality. Diagnosis of frailty could improve prognostication and identify a vulnerable population that might benefit from follow-up and intervention.
Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We determined the prevalence, correlates and outcomes associated with frailty among adults admitted to intensive care. We prospectively enrolled 421 critically ill adults aged 50 or more at 6 hospitals across the province of Alberta. The primary exposure was frailty, defined by a score greater than 4 on the Clinical Frailty Scale. The primary outcome measure was in-hospital mortality. Secondary outcome measures included adverse events, 1-year mortality and quality of life. The prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more comorbidities and greater functional dependence than those who were not frail. In-hospital mortality was higher among frail patients than among non-frail patients (32% v. 16%; adjusted odds ratio [OR] 1.81, 95% CI 1.09-3.01) and remained higher at 1 year (48% v. 25%; adjusted hazard ratio 1.82, 95% CI 1.28-2.60). Major adverse events were more common among frail patients (39% v. 29%; OR 1.54, 95% CI 1.01-2.37). Compared with nonfrail survivors, frail survivors were more likely to become functionally dependent (71% v. 52%; OR 2.25, 95% CI 1.03-4.89), had significantly lower quality of life and were more often readmitted to hospital (56% v. 39%; OR 1.98, 95% CI 1.22-3.23) in the 12 months following enrolment. Frailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and mortality. Diagnosis of frailty could improve prognostication and identify a vulnerable population that might benefit from follow-up and intervention.
Results: The prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more comorbidities and greater functional dependence than those who were not frail. In-hospital mortality was higher among frail patients than among nonfrail patients (32% v. 16%; adjusted odds ratio [OR] 1.81, 95% CI 1.09-3.01) and remained higher at 1 year (48% v. 25%; adjusted hazard ratio 1.82, 95% CI 1.28-2.60). Major adverse events were more common among frail patients (39% v. 29%; OR 1.54, 95% CI 1.01-2.37). Compared with nonfrail survivors, frail survivors were more likely to become functionally dependent (71% v. 52%; OR 2.25, 95% CI 1.03-4.89), had significantly lower quality of life and were more often readmitted to hospital (56% v. 39%; OR 1.98, 95% CI 1.22-3.23) in the 12 months following enrolment. In this prospective multicentre study of a representative cohort of critically ill patients over the age of 50, we found that frailty was common, affecting one-third of the participants. Frail patients differed from nonfrail patients in many sociodemographic and clinical characteristics, including having a greater burden of comorbid illness and functional impairment at ICU admission. Despite both groups having similar treatment intensity, frail patients were more likely to experience adverse events, had longer lengths of stay in ICU and hospital, and were more likely to die while in hospital and within 12 months after admission. Among survivors, frail patients were more likely than nonfrail patients to have new functional dependence at hospital discharge and had higher rates of hospital readmission. There was a similar disadvantage for frail patients for worse health-related quality of life across all domains measured. These associations were stronger with increasing severity of frailty and persisted even after adjustment for sociodemographic factors, premorbid health status, comorbidities and illness severity. Frailty is generally viewed as an age-associated loss of reserve across multiple physiologic and cognitive systems that give rise to susceptibility to adverse events.1,2 A variety of operational definitions have been applied to encapsulate the frail state across clinical contexts; however, none has been used to describe frailty among a generalizable cohort with critical illness.34 Similarly, other measures of performance status have been integrated into studies involving critically ill patients, generally for risk adjustment; however, they have not been evaluated in the context of frailty.35,36 Data from the Canadian National Population Health Survey showed that the prevalence of frailty was about 7% and that it increased exponentially with age.4 In a vulnerable cohort of older outpatients, the prevalence of frailty was 59%.3 We found frailty in 33% of the critically ill patients enrolled in our study, an estimate between the extremes of the general population and an older outpatient population. Notably, our cohort was relatively young compared with these cohorts, implying the susceptibility to critical illness may be "age-shifted" in those with frailty. This suggests that an episode of critical illness in a frail patient may herald a momentous transition toward greater homeostatic instability, disability and risk of death.11
Background: Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We determined the prevalence, correlates and outcomes associated with frailty among adults admitted to intensive care. Methods: We prospectively enrolled 421 critically ill adults aged 50 or more at 6 hospitals across the province of Alberta. The primary exposure was frailty, defined by a score greater than 4 on the Clinical Frailty Scale. The primary outcome measure was in-hospital mortality. Secondary outcome measures included adverse events, 1-year mortality and quality of life. Results: The prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more comorbidities and greater functional dependence than those who were not frail. In-hospital mortality was higher among frail patients than among nonfrail patients (32% v. 16%; adjusted odds ratio [OR] 1.81, 95% CI 1.09-3.01) and remained higher at 1 year (48% v. 25%; adjusted hazard ratio 1.82, 95% CI 1.28-2.60). Major adverse events were more common among frail patients (39% v. 29%; OR 1.54, 95% CI 1.01-2.37). Compared with nonfrail survivors, frail survivors were more likely to become functionally dependent (71% v. 52%; OR 2.25, 95% CI 1.03-4.89), had significantly lower quality of life and were more often readmitted to hospital (56% v. 39%; OR 1.98, 95% CI 1.22-3.23) in the 12 months following enrolment. Interpretation: Frailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and mortality. Diagnosis of frailty could improve prognostication and identify a vulnerable population that might benefit from follow-up and intervention. 39 references
Audience Professional
Author Rokosh, Ella
Baig, Nadia
Tsuyuki, Ross T.
Majumdar, Sumit R.
Bagshaw, Sean M.
McDermid, Robert C.
Stelfox, H. Thomas
Artiuch, Barbara
Stollery, Daniel E.
Rolfson, Darryl B.
Ibrahim, Quazi
Author_xml – sequence: 1
  givenname: Sean M.
  surname: Bagshaw
  fullname: Bagshaw, Sean M.
– sequence: 2
  givenname: H. Thomas
  surname: Stelfox
  fullname: Stelfox, H. Thomas
– sequence: 3
  givenname: Robert C.
  surname: McDermid
  fullname: McDermid, Robert C.
– sequence: 4
  givenname: Darryl B.
  surname: Rolfson
  fullname: Rolfson, Darryl B.
– sequence: 5
  givenname: Ross T.
  surname: Tsuyuki
  fullname: Tsuyuki, Ross T.
– sequence: 6
  givenname: Nadia
  surname: Baig
  fullname: Baig, Nadia
– sequence: 7
  givenname: Barbara
  surname: Artiuch
  fullname: Artiuch, Barbara
– sequence: 8
  givenname: Quazi
  surname: Ibrahim
  fullname: Ibrahim, Quazi
– sequence: 9
  givenname: Daniel E.
  surname: Stollery
  fullname: Stollery, Daniel E.
– sequence: 10
  givenname: Ella
  surname: Rokosh
  fullname: Rokosh, Ella
– sequence: 11
  givenname: Sumit R.
  surname: Majumdar
  fullname: Majumdar, Sumit R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24277703$$D View this record in MEDLINE/PubMed
BookMark eNqVk81v0zAUwCM0xLrBiTuyQEIglGLHiZ1wQKomPiZNIPFxtlznpXXl2FnsbOuZfxyn3aCdeoDkEMf-vZ9sv_dOkiPrLCTJU4KnpMD0rWrlakooZrR6kExIXpZpRrPqKJngMsMprXJ2nJx4v8LxoRl_lBxnecY5x3SS_Jp575SWQTuL5hCuASxqeqlNWCNpa-SXrg_pZmicXaQB-ha5ISjXgkeyjXNI9TpoJY1ZI20M6qINbPDvkETtYOJS_OsBdb3zHaigrwApN3qRD0O9fpw8bKTx8OT2e5r8_Pjhx9nn9OLrp_Oz2UWqOK1C2hCeASsUpoyVFbC6mJeUSFUSwhgv5kTNScYz3HBJm7qhNasrzKACkuMal4SeJu-33m6Yt1BvdiWN6Hrdyn4tnNRif8XqpVi4K0ErTDnLo-DVraB3lwP4IFrtFRgjLbjBC1KQPCec_AuaVxXJ4kFYRF_cQ1du6G28iSjEvGCUVfQvtZAGhLaNi1tUo1TMKCMxo4SPrvQAtQAL8TyxbBodp_f45wd41elLsQtND0DxraHV6qD19V5AZALchIUcvBfn37_9B_tln325wy5BmrD0zgxj8fp98Nlupv-k-K7uI0C2gIo16XtohNJh0wRhrH1B8Hj3VIy9Jba9FWPe3Iu50x6ifwNueCFX
CODEN CMAJAX
CitedBy_id crossref_primary_10_1080_15265161_2020_1851809
crossref_primary_10_1177_1751143720985164
crossref_primary_10_1016_j_chest_2024_04_039
crossref_primary_10_1371_journal_pone_0270455
crossref_primary_10_1016_j_aucc_2023_06_008
crossref_primary_10_1213_ANE_0000000000004665
crossref_primary_10_14283_jfa_2018_29
crossref_primary_10_1186_s12871_016_0276_0
crossref_primary_10_1038_s41598_020_65807_2
crossref_primary_10_1097_CCM_0000000000002599
crossref_primary_10_1111_jgs_13783
crossref_primary_10_2215_CJN_05530518
crossref_primary_10_1097_CCM_0000000000000860
crossref_primary_10_1016_j_anclin_2019_04_008
crossref_primary_10_1007_s00134_022_06887_8
crossref_primary_10_1097_CCM_0000000000002243
crossref_primary_10_1186_s13054_020_03017_y
crossref_primary_10_1038_s41598_023_32519_2
crossref_primary_10_1186_s40064_015_1307_x
crossref_primary_10_1016_j_jcrc_2016_06_002
crossref_primary_10_1177_1751143718804678
crossref_primary_10_1213_ANE_0000000000004792
crossref_primary_10_2196_19859
crossref_primary_10_1016_j_jamda_2024_105295
crossref_primary_10_1007_s40520_016_0557_y
crossref_primary_10_1007_s12630_019_01414_8
crossref_primary_10_1016_j_chest_2020_07_018
crossref_primary_10_3389_fpsyt_2021_713386
crossref_primary_10_1016_j_aucc_2021_06_012
crossref_primary_10_2215_CJN_07760814
crossref_primary_10_1016_j_arr_2022_101832
crossref_primary_10_1017_S0714980819000205
crossref_primary_10_1097_CCM_0000000000001024
crossref_primary_10_1097_EJA_0000000000000678
crossref_primary_10_3389_fpsyg_2020_00564
crossref_primary_10_1016_j_medine_2020_05_015
crossref_primary_10_1097_CCE_0000000000000777
crossref_primary_10_1136_bmjopen_2018_025228
crossref_primary_10_1097_CCE_0000000000001184
crossref_primary_10_1093_bjsopen_zrae078
crossref_primary_10_1097_PRS_0000000000008573
crossref_primary_10_1093_cid_ciab341
crossref_primary_10_1213_ANE_0000000000004687
crossref_primary_10_1186_s13054_018_2136_4
crossref_primary_10_14283_jfa_2019_12
crossref_primary_10_1016_j_mad_2021_111546
crossref_primary_10_1186_s44158_025_00268_5
crossref_primary_10_1097_CCM_0000000000004443
crossref_primary_10_1186_s12944_024_02221_x
crossref_primary_10_1016_j_aucc_2023_11_008
crossref_primary_10_1097_CCM_0000000000004444
crossref_primary_10_1371_journal_pone_0207883
crossref_primary_10_23736_S0021_9509_24_13052_2
crossref_primary_10_1016_j_jamda_2020_04_034
crossref_primary_10_1186_s13613_016_0161_5
crossref_primary_10_1016_j_jcrc_2018_02_004
crossref_primary_10_1016_j_jamda_2017_04_018
crossref_primary_10_1097_ALN_0000000000001537
crossref_primary_10_1177_0885066619881115
crossref_primary_10_1016_j_medin_2020_05_019
crossref_primary_10_1111_aas_14343
crossref_primary_10_3389_fmed_2014_00061
crossref_primary_10_1080_17476348_2020_1743182
crossref_primary_10_1007_s00134_015_4028_2
crossref_primary_10_1016_j_archger_2018_11_002
crossref_primary_10_1177_0148607114567710
crossref_primary_10_1016_j_resplu_2022_100266
crossref_primary_10_1097_CCM_0000000000003218
crossref_primary_10_2340_1651_226X_2025_42292
crossref_primary_10_1016_j_jcrc_2023_154398
crossref_primary_10_12968_hmed_2016_77_2_102
crossref_primary_10_14283_jfa_2019_20
crossref_primary_10_1177_2192568219894951
crossref_primary_10_12968_ijpn_2022_28_12_590
crossref_primary_10_1007_s13670_018_0254_0
crossref_primary_10_1016_j_chest_2021_12_658
crossref_primary_10_1186_s13054_021_03794_0
crossref_primary_10_1371_journal_pone_0317305
crossref_primary_10_1016_j_jcrc_2020_08_024
crossref_primary_10_1007_s00134_016_4595_x
crossref_primary_10_1007_s10815_023_02979_6
crossref_primary_10_1007_s11357_024_01472_x
crossref_primary_10_1097_CCM_0000000000003465
crossref_primary_10_1164_rccm_201312_2257OC
crossref_primary_10_1186_s40814_016_0104_9
crossref_primary_10_1007_s12630_020_01610_x
crossref_primary_10_1111_aas_13121
crossref_primary_10_1080_23744235_2022_2060304
crossref_primary_10_1186_s13054_016_1338_x
crossref_primary_10_1016_j_ccc_2018_06_007
crossref_primary_10_1007_s00134_018_5273_y
crossref_primary_10_1007_s13546_014_1009_3
crossref_primary_10_1097_CCM_0000000000001903
crossref_primary_10_1016_j_amjsurg_2019_01_035
crossref_primary_10_1097_TA_0000000000000981
crossref_primary_10_1016_j_medin_2025_502259
crossref_primary_10_1007_s00134_017_4974_y
crossref_primary_10_1093_ageing_afab107
crossref_primary_10_1183_23120541_00808_2020
crossref_primary_10_1017_S1047951125100863
crossref_primary_10_1161_CIR_0000000000000741
crossref_primary_10_1111_nicc_12787
crossref_primary_10_1186_s13054_020_03420_5
crossref_primary_10_1007_s40520_017_0774_z
crossref_primary_10_4037_ccn2018336
crossref_primary_10_1016_j_bja_2021_11_018
crossref_primary_10_1097_EJA_0000000000001156
crossref_primary_10_1186_s13054_017_1704_3
crossref_primary_10_1111_anae_14596
crossref_primary_10_1111_jgs_19438
crossref_primary_10_1186_s13054_018_1953_9
crossref_primary_10_14283_jfa_2023_27
crossref_primary_10_1016_j_medine_2025_502259
crossref_primary_10_1111_aas_13555
crossref_primary_10_1097_CCM_0000000000000924
crossref_primary_10_2147_CIA_S388160
crossref_primary_10_1002_jcsm_12966
crossref_primary_10_14309_ctg_0000000000000211
crossref_primary_10_1007_s00268_020_05742_5
crossref_primary_10_1186_s13643_021_01638_0
crossref_primary_10_1016_j_jnha_2025_100490
crossref_primary_10_1016_j_jcrc_2018_04_012
crossref_primary_10_62675_2965_2774_20250229
crossref_primary_10_1513_AnnalsATS_201612_1008OC
crossref_primary_10_1016_j_chest_2021_06_009
crossref_primary_10_1136_bmjopen_2023_075685
crossref_primary_10_1186_s13054_022_04177_9
crossref_primary_10_1186_s40560_020_00494_9
crossref_primary_10_1016_j_enfi_2025_500558
crossref_primary_10_1097_CCE_0000000000001300
crossref_primary_10_1002_nop2_1873
crossref_primary_10_1164_rccm_201407_1263ED
crossref_primary_10_1111_ans_15633
crossref_primary_10_1007_s40141_015_0099_9
crossref_primary_10_1111_aas_14418
crossref_primary_10_1177_23779608211038845
crossref_primary_10_1007_s00134_016_4479_0
crossref_primary_10_5005_jp_journals_10071_24959
crossref_primary_10_1038_s41598_022_18970_7
crossref_primary_10_1177_1751143719838212
crossref_primary_10_1136_bmjopen_2016_011659
crossref_primary_10_1145_3710937
crossref_primary_10_1007_s40137_017_0193_2
crossref_primary_10_1111_jan_15120
crossref_primary_10_1186_s40560_019_0385_1
crossref_primary_10_7861_fhj_2023_0014
crossref_primary_10_1016_j_injury_2025_112514
crossref_primary_10_1016_j_jamda_2020_12_034
crossref_primary_10_51893_2020_1_oa6
crossref_primary_10_1016_j_medin_2019_07_006
crossref_primary_10_1097_CCM_0000000000001377
crossref_primary_10_1016_j_bja_2025_03_002
crossref_primary_10_1097_MCC_0000000000001188
crossref_primary_10_1002_cncr_32397
crossref_primary_10_3390_geriatrics3030039
crossref_primary_10_1159_000540323
crossref_primary_10_1016_S2213_2600_22_00248_X
crossref_primary_10_4037_ajcc2023858
crossref_primary_10_1002_jpen_1449
crossref_primary_10_1007_s00134_018_5054_7
crossref_primary_10_1002_jhm_2607
crossref_primary_10_1016_j_ccrj_2023_11_001
crossref_primary_10_5005_jp_journals_10071_24949
crossref_primary_10_1016_j_jcrc_2024_154930
crossref_primary_10_1093_ptj_pzz057
crossref_primary_10_1186_s13613_022_01098_2
crossref_primary_10_1007_s00134_018_5262_1
crossref_primary_10_1161_CIRCULATIONAHA_115_018006
crossref_primary_10_1186_s13054_015_0892_y
crossref_primary_10_1177_14799731241240786
crossref_primary_10_1007_s00380_021_01883_2
crossref_primary_10_1016_j_aucc_2024_06_011
crossref_primary_10_1097_MCC_0000000000001197
crossref_primary_10_4046_trd_2024_0160
crossref_primary_10_1513_AnnalsATS_201710_793IP
crossref_primary_10_1017_S0714980816000301
crossref_primary_10_1371_journal_pone_0248883
crossref_primary_10_5694_mja2_50329
crossref_primary_10_1007_s12630_022_02335_9
crossref_primary_10_1186_s13054_020_03318_2
crossref_primary_10_1111_nicc_70109
crossref_primary_10_1007_s40520_015_0462_9
crossref_primary_10_1016_j_jcrc_2018_01_012
crossref_primary_10_1016_j_jcrc_2024_154842
crossref_primary_10_1097_SLA_0000000000001546
crossref_primary_10_4037_ajcc2019285
crossref_primary_10_1001_jama_2024_20631
crossref_primary_10_1097_TGR_0000000000000081
crossref_primary_10_9778_cmajo_20200034
crossref_primary_10_1097_CCM_0000000000003722
crossref_primary_10_1097_CCM_0000000000003727
crossref_primary_10_1038_s41598_019_55459_2
crossref_primary_10_1186_s13054_021_03632_3
crossref_primary_10_1186_s12877_018_0890_4
crossref_primary_10_1016_j_jcrc_2020_06_007
crossref_primary_10_1097_CCM_0000000000006684
crossref_primary_10_1136_bmjopen_2015_008457
crossref_primary_10_1111_anae_15644
crossref_primary_10_1007_s12630_022_02270_9
crossref_primary_10_1080_00015458_2017_1337339
crossref_primary_10_1177_2047487316682579
crossref_primary_10_1007_s00134_019_05795_8
crossref_primary_10_1007_s10620_023_08013_0
crossref_primary_10_1016_j_clnu_2015_07_003
crossref_primary_10_1016_j_ccrj_2024_02_001
crossref_primary_10_1111_ggi_12955
crossref_primary_10_1007_s00345_024_04895_5
crossref_primary_10_1186_s13613_024_01315_0
crossref_primary_10_1007_s12630_019_01411_x
crossref_primary_10_1016_j_aucc_2019_11_001
crossref_primary_10_1007_s12630_014_0273_z
crossref_primary_10_1111_imj_13805
crossref_primary_10_1177_0310057X1504300313
crossref_primary_10_1186_s13063_019_3834_1
crossref_primary_10_1016_j_ejim_2017_09_026
crossref_primary_10_1213_ANE_0000000000001560
crossref_primary_10_1016_j_jcrc_2024_154833
crossref_primary_10_1016_j_aucc_2017_11_005
crossref_primary_10_1016_j_enfi_2023_07_003
crossref_primary_10_1016_j_jpainsymman_2022_02_344
crossref_primary_10_1136_bmjopen_2020_047051
crossref_primary_10_1097_CCM_0000000000003831
crossref_primary_10_1016_j_aucc_2021_08_005
crossref_primary_10_1016_j_medin_2020_11_003
crossref_primary_10_1097_CCM_0000000000006669
crossref_primary_10_1136_bmj_k4135
crossref_primary_10_1007_s12630_023_02590_4
crossref_primary_10_1186_s12871_025_03096_w
crossref_primary_10_1093_qjmed_hcv066
crossref_primary_10_1177_17511437231199897
crossref_primary_10_1097_CCM_0000000000002074
crossref_primary_10_1371_journal_pone_0143088
crossref_primary_10_5492_wjccm_v6_i1_48
crossref_primary_10_1016_j_cjca_2016_05_011
crossref_primary_10_1016_j_medine_2019_07_003
crossref_primary_10_1016_j_jcrc_2017_11_017
crossref_primary_10_1186_s13613_023_01132_x
crossref_primary_10_1007_s00134_024_07518_0
crossref_primary_10_1016_j_jgo_2021_12_013
crossref_primary_10_1513_AnnalsATS_201412_568OC
crossref_primary_10_1016_j_aohep_2024_101515
crossref_primary_10_2196_54451
crossref_primary_10_1007_s00134_016_4477_2
crossref_primary_10_1016_j_jamda_2017_10_006
crossref_primary_10_1097_TA_0000000000002583
crossref_primary_10_1016_S1441_2772_23_00917_1
crossref_primary_10_1186_1471_2253_14_59
crossref_primary_10_3390_jcm14051760
crossref_primary_10_1513_AnnalsATS_201902_116OC
crossref_primary_10_5005_jaypee_journals_10071_24933_45
crossref_primary_10_1007_s00134_016_4563_5
crossref_primary_10_1016_j_jcrc_2018_05_013
crossref_primary_10_1038_ajg_2016_303
crossref_primary_10_1186_s13613_020_00672_w
crossref_primary_10_1136_bmjopen_2019_036047
crossref_primary_10_1016_j_surg_2016_04_015
crossref_primary_10_3390_jcm12083010
crossref_primary_10_1016_j_ejim_2016_04_002
crossref_primary_10_1016_j_enfie_2025_500558
crossref_primary_10_1111_jep_13096
crossref_primary_10_1097_SLA_0000000000002967
crossref_primary_10_2147_CIA_S481610
crossref_primary_10_1186_s13054_021_03788_y
crossref_primary_10_1007_s12603_023_1961_6
crossref_primary_10_1017_cem_2015_73
crossref_primary_10_1016_j_chest_2018_03_007
crossref_primary_10_1186_s13613_024_01261_x
crossref_primary_10_1016_j_resuscitation_2019_11_011
crossref_primary_10_1097_CCM_0000000000005488
crossref_primary_10_1007_s00134_024_07364_0
crossref_primary_10_1016_j_iccn_2020_102981
crossref_primary_10_1097_CCE_0000000000000712
crossref_primary_10_1007_s10620_023_07830_7
crossref_primary_10_1097_MCC_0000000000000342
crossref_primary_10_1177_0898264314558202
crossref_primary_10_1016_j_medine_2022_02_008
crossref_primary_10_1080_24745332_2020_1769436
crossref_primary_10_1177_0885066620939055
crossref_primary_10_1186_s40635_022_00446_7
crossref_primary_10_1111_jgs_18196
crossref_primary_10_4253_wjge_v16_i3_148
crossref_primary_10_1007_s00391_016_1128_8
crossref_primary_10_1016_j_jcrc_2019_10_018
crossref_primary_10_1093_jcag_gwab025
crossref_primary_10_1097_MCC_0000000000000149
crossref_primary_10_1007_s00134_024_07404_9
crossref_primary_10_1016_j_enfie_2023_07_007
crossref_primary_10_1097_CCM_0000000000001627
crossref_primary_10_1002_pri_2070
crossref_primary_10_1016_j_jcrc_2019_10_016
crossref_primary_10_1186_s12916_020_01761_0
crossref_primary_10_1016_j_jcrc_2019_04_032
crossref_primary_10_1111_imj_15352
crossref_primary_10_1007_s00134_014_3246_3
crossref_primary_10_1513_AnnalsATS_202102_178OC
crossref_primary_10_1002_wjs_12141
crossref_primary_10_1016_j_suc_2017_07_007
crossref_primary_10_1513_AnnalsATS_201607_538OC
crossref_primary_10_1016_j_aucc_2024_09_013
crossref_primary_10_1016_j_resuscitation_2022_07_013
crossref_primary_10_5005_jp_journals_10071_24456
crossref_primary_10_1590_0104_1169_0660_2657
crossref_primary_10_1177_0269216319828650
crossref_primary_10_1097_TA_0000000000003864
crossref_primary_10_1186_s13054_021_03510_y
crossref_primary_10_1097_CCE_0000000000000616
crossref_primary_10_1016_j_chest_2021_05_049
crossref_primary_10_1186_s12877_022_03063_x
crossref_primary_10_1513_AnnalsATS_201512_833FR
crossref_primary_10_1097_CCM_0000000000000892
crossref_primary_10_1007_s00134_021_06438_7
crossref_primary_10_1111_aas_13021
crossref_primary_10_1186_s13054_022_03987_1
crossref_primary_10_1097_TA_0000000000001329
crossref_primary_10_1111_jocn_14318
crossref_primary_10_1007_s00134_018_5440_1
crossref_primary_10_1164_rccm_201605_0939OC
crossref_primary_10_1177_0885066620944865
crossref_primary_10_1186_s13054_017_1688_z
crossref_primary_10_3389_fmed_2021_748812
crossref_primary_10_1016_j_ejim_2020_11_024
crossref_primary_10_3389_fpubh_2023_1086215
crossref_primary_10_1097_CCM_0000000000001645
crossref_primary_10_1111_anae_14617
crossref_primary_10_1513_AnnalsATS_202207_630OC
crossref_primary_10_3389_fmed_2023_1071854
crossref_primary_10_1097_BOT_0000000000001518
crossref_primary_10_1016_j_injury_2017_08_026
crossref_primary_10_1093_ehjacc_zuae039
crossref_primary_10_1164_rccm_201410_1907LE
crossref_primary_10_1136_bmjspcare_2017_001441
crossref_primary_10_1007_s00134_018_5342_2
crossref_primary_10_1007_s13193_024_01995_x
crossref_primary_10_1111_jgs_16788
crossref_primary_10_1016_j_jcrc_2020_11_021
crossref_primary_10_1111_jgs_16427
crossref_primary_10_1186_s12877_020_01893_1
crossref_primary_10_1016_j_bja_2020_07_049
crossref_primary_10_1016_j_jcrc_2015_05_018
crossref_primary_10_1016_j_clnu_2021_09_017
crossref_primary_10_1097_CCM_0000000000006663
crossref_primary_10_1007_s12603_015_0567_z
crossref_primary_10_1136_bmjopen_2016_012590
crossref_primary_10_14283_jfa_2020_52
crossref_primary_10_1097_CCE_0000000000000066
crossref_primary_10_3389_fsurg_2023_1031409
crossref_primary_10_1007_s11357_025_01864_7
crossref_primary_10_1177_0310057X19856895
crossref_primary_10_1111_aas_13836
crossref_primary_10_1097_SHK_0000000000002517
crossref_primary_10_1177_08258597211020964
crossref_primary_10_1038_s41598_020_62477_y
crossref_primary_10_1007_s00134_023_07298_z
crossref_primary_10_1186_s12877_021_02586_z
crossref_primary_10_1007_s00134_017_4867_0
crossref_primary_10_1111_jocn_16078
crossref_primary_10_1111_imj_16458
crossref_primary_10_1186_s13054_025_05431_6
crossref_primary_10_1136_bmjopen_2018_022057
crossref_primary_10_1089_jpm_2019_0678
crossref_primary_10_1097_CCM_0000000000001762
crossref_primary_10_1111_ejh_14366
crossref_primary_10_1093_bjsopen_zrae171
crossref_primary_10_1097_CCM_0000000000006773
crossref_primary_10_1136_bmj_l6373
crossref_primary_10_1186_s13054_022_04247_y
crossref_primary_10_1177_0310057X1704500310
crossref_primary_10_1186_s12877_017_0518_0
crossref_primary_10_1111_ggi_12827
crossref_primary_10_1111_aas_13286
crossref_primary_10_1513_AnnalsATS_201503_171ED
crossref_primary_10_1016_j_injury_2019_07_026
ContentType Journal Article
Copyright COPYRIGHT 2014 Joule Inc.
Copyright Canadian Medical Association Feb 4, 2014
1995-2014, Canadian Medical Association 2014
Copyright_xml – notice: COPYRIGHT 2014 Joule Inc.
– notice: Copyright Canadian Medical Association Feb 4, 2014
– notice: 1995-2014, Canadian Medical Association 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISN
ISR
3V.
4T-
4U-
7RV
7X7
7XB
88E
88G
88I
8AF
8AO
8FI
8FJ
8FK
8FQ
8FV
8G5
ABUWG
AFKRA
AN0
ASE
AZQEC
BENPR
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K6X
K9.
KB0
M0S
M0T
M1P
M2M
M2O
M2P
M3G
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1503/cmaj.130639
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Canada
Gale In Context: Science
ProQuest Central (Corporate)
Docstoc
University Readers
Nursing & Allied Health Database (ProQuest)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Canadian Business & Current Affairs Database
Canadian Business & Current Affairs Database (Alumni)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
British Nursing Index
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Healthcare Administration Database
PML(ProQuest Medical Library)
Psychology Database
Research Library
Science Database
CBCA Reference & Current Events
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
CBCA Complete (Alumni Edition)
Health Research Premium Collection
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Docstoc
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
University Readers
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
CBCA Complete
ProQuest Research Library
ProQuest Central Basic
ProQuest Science Journals
CBCA Reference & Current Events
British Nursing Index with Full Text
ProQuest Health Management
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Psychology Journals (Alumni)
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

MEDLINE
ProQuest One Psychology


British Nursing Index


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1488-2329
EndPage E102
ExternalDocumentID PMC3903764
3246828541
A361242176
24277703
10_1503_cmaj_130639
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GeographicLocations Alberta Canada
Canada
GeographicLocations_xml – name: Canada
– name: Alberta Canada
GrantInformation_xml – fundername: Canadian Institutes of Health Research
  grantid: MOP 111044
GroupedDBID ---
.1-
.FO
.XZ
00U
18M
1P~
29B
2QL
2WC
354
36B
4.4
4IJ
5GY
5RS
6PF
7RV
7X7
88E
88I
8AF
8AO
8F7
8FI
8FJ
8FQ
8G5
AAFWJ
AAWTL
AAYXX
ABIVO
ABOCM
ABPMR
ABUWG
ACGOD
ACIHN
ADBBV
AEAQA
AENEX
AEVXI
AFCHL
AFFHD
AFKRA
AFPKN
AFRHN
AHMBA
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BENPR
BKEYQ
BNQBC
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EMB
EMOBN
EX3
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HCIFZ
HMCUK
HYE
IAO
ICQ
IEA
IHR
IHW
INH
INR
IOF
IPT
ISN
ISR
ITC
L7B
M0T
M1P
M2M
M2O
M2P
M2Q
M3C
M3G
M5~
NAPCQ
OBH
OCB
OD.
ODZKP
OFXIZ
OGEVE
OHH
OO~
OVD
OVIDX
OVT
P2P
PCD
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RDH
RHI
RPM
SV3
TEORI
U5U
UKHRP
VVN
WH7
WOQ
WOW
X6Y
YFH
YOC
Z5R
~H1
AFCTW
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
4T-
4U-
7XB
8FK
ASE
FPQ
K6X
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c739t-f172e65c036689e6d5b831ac8116675b1cb12720f7a3fdf3d6d906e9e140d0813
IEDL.DBID M2P
ISICitedReferencesCount 398
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000330267300016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0820-3946
1488-2329
IngestDate Tue Nov 04 01:57:37 EST 2025
Sun Nov 09 12:10:25 EST 2025
Thu Sep 04 19:25:53 EDT 2025
Mon Oct 06 18:35:09 EDT 2025
Tue Nov 11 10:13:43 EST 2025
Sat Nov 29 11:28:20 EST 2025
Tue Jun 10 15:35:07 EDT 2025
Tue Nov 04 17:52:12 EST 2025
Thu Nov 13 14:36:22 EST 2025
Thu Nov 13 15:09:58 EST 2025
Thu May 22 21:22:03 EDT 2025
Thu Apr 03 07:04:27 EDT 2025
Sat Nov 29 03:45:03 EST 2025
Tue Nov 18 21:06:02 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c739t-f172e65c036689e6d5b831ac8116675b1cb12720f7a3fdf3d6d906e9e140d0813
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.cmaj.ca/content/cmaj/186/2/E95.full.pdf
PMID 24277703
PQID 1507563693
PQPubID 41339
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3903764
proquest_miscellaneous_1514417164
proquest_miscellaneous_1499126686
proquest_journals_1507563693
gale_infotracmisc_A361242176
gale_infotracgeneralonefile_A361242176
gale_infotraccpiq_361242176
gale_infotracacademiconefile_A361242176
gale_incontextgauss_ISR_A361242176
gale_incontextgauss_ISN_A361242176
gale_healthsolutions_A361242176
pubmed_primary_24277703
crossref_citationtrail_10_1503_cmaj_130639
crossref_primary_10_1503_cmaj_130639
PublicationCentury 2000
PublicationDate 2014-02-04
PublicationDateYYYYMMDD 2014-02-04
PublicationDate_xml – month: 02
  year: 2014
  text: 2014-02-04
  day: 04
PublicationDecade 2010
PublicationPlace Canada
PublicationPlace_xml – name: Canada
– name: Ottawa
PublicationSubtitle CMAJ
PublicationTitle Canadian Medical Association journal (CMAJ)
PublicationTitleAlternate CMAJ
PublicationYear 2014
Publisher Joule Inc
CMA Impact, Inc
Canadian Medical Association
Publisher_xml – name: Joule Inc
– name: CMA Impact, Inc
– name: Canadian Medical Association
References 21345259 - Crit Care. 2011;15(1):301
22348303 - Br J Clin Pharmacol. 2012 Sep;74(3):411-23
19615630 - J Pain Symptom Manage. 2009 Jul;38(1):75-80
23067364 - BMC Med. 2012;10:120
8844239 - Intensive Care Med. 1996 Jul;22(7):707-10
22091571 - J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S262-8
23395245 - Lancet. 2013 Mar 2;381(9868):752-62
12395026 - Med Care. 2002 Oct;40(10):929-40
21540166 - CMAJ. 2011 May 17;183(8):E487-94
16763517 - Crit Care Med. 2006 Aug;34(8):2120-6
23773812 - BMC Anesthesiol. 2013 Jun 18;13:11
10630726 - Med Care. 2000 Jan;38(1):115-21
21215580 - J Vasc Surg. 2011 Apr;53(4):912-7
20843962 - Age Ageing. 2010 Nov;39(6):758-61
16107450 - Age Ageing. 2005 Sep;34(5):432-4
20005123 - Crit Rev Oncol Hematol. 2010 Dec;76(3):208-17
19446324 - Lancet. 2009 May 30;373(9678):1874-82
18068828 - Arch Gerontol Geriatr. 2009 Jan-Feb;48(1):78-83
21294911 - Health Qual Life Outcomes. 2011;9:9
3928249 - Crit Care Med. 1985 Oct;13(10):818-29
20510798 - J Am Coll Surg. 2010 Jun;210(6):901-8
23344834 - Intensive Care Med. 2013 May;39(5):910-8
15066083 - J Am Geriatr Soc. 2004 Apr;52(4):625-34
20159833 - Circulation. 2010 Mar 2;121(8):973-8
20019120 - Clin J Am Soc Nephrol. 2010 Feb;5(2):252-60
9431328 - Med Care. 1998 Jan;36(1):8-27
21926598 - Crit Care Med. 2012 Jan;40(1):125-31
18384589 - J Am Geriatr Soc. 2008 May;56(5):816-22
20627611 - Eur J Cardiothorac Surg. 2011 Jan;39(1):33-7
15031310 - J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
22742913 - J Clin Epidemiol. 2012 Sep;65(9):989-95
19088351 - JAMA. 2008 Dec 17;300(23):2731-41
20357280 - N Engl J Med. 2010 Apr 1;362(13):1173-80
20179286 - JAMA. 2010 Feb 24;303(8):763-70
16129869 - CMAJ. 2005 Aug 30;173(5):489-95
24088092 - N Engl J Med. 2013 Oct 3;369(14):1306-16
21972312 - JAMA. 2011 Oct 5;306(13):1483-4
15523072 - JAMA. 2004 Nov 3;292(17):2115-24
11897015 - BMC Geriatr. 2002 Feb 27;2:1
References_xml – reference: 21215580 - J Vasc Surg. 2011 Apr;53(4):912-7
– reference: 19615630 - J Pain Symptom Manage. 2009 Jul;38(1):75-80
– reference: 23773812 - BMC Anesthesiol. 2013 Jun 18;13:11
– reference: 20627611 - Eur J Cardiothorac Surg. 2011 Jan;39(1):33-7
– reference: 21294911 - Health Qual Life Outcomes. 2011;9:9
– reference: 11897015 - BMC Geriatr. 2002 Feb 27;2:1
– reference: 22742913 - J Clin Epidemiol. 2012 Sep;65(9):989-95
– reference: 20843962 - Age Ageing. 2010 Nov;39(6):758-61
– reference: 20159833 - Circulation. 2010 Mar 2;121(8):973-8
– reference: 20357280 - N Engl J Med. 2010 Apr 1;362(13):1173-80
– reference: 16107450 - Age Ageing. 2005 Sep;34(5):432-4
– reference: 8844239 - Intensive Care Med. 1996 Jul;22(7):707-10
– reference: 21345259 - Crit Care. 2011;15(1):301
– reference: 20179286 - JAMA. 2010 Feb 24;303(8):763-70
– reference: 22348303 - Br J Clin Pharmacol. 2012 Sep;74(3):411-23
– reference: 18068828 - Arch Gerontol Geriatr. 2009 Jan-Feb;48(1):78-83
– reference: 23395245 - Lancet. 2013 Mar 2;381(9868):752-62
– reference: 15523072 - JAMA. 2004 Nov 3;292(17):2115-24
– reference: 18384589 - J Am Geriatr Soc. 2008 May;56(5):816-22
– reference: 23344834 - Intensive Care Med. 2013 May;39(5):910-8
– reference: 21972312 - JAMA. 2011 Oct 5;306(13):1483-4
– reference: 15066083 - J Am Geriatr Soc. 2004 Apr;52(4):625-34
– reference: 19088351 - JAMA. 2008 Dec 17;300(23):2731-41
– reference: 19446324 - Lancet. 2009 May 30;373(9678):1874-82
– reference: 9431328 - Med Care. 1998 Jan;36(1):8-27
– reference: 20019120 - Clin J Am Soc Nephrol. 2010 Feb;5(2):252-60
– reference: 15031310 - J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
– reference: 16763517 - Crit Care Med. 2006 Aug;34(8):2120-6
– reference: 21540166 - CMAJ. 2011 May 17;183(8):E487-94
– reference: 20005123 - Crit Rev Oncol Hematol. 2010 Dec;76(3):208-17
– reference: 10630726 - Med Care. 2000 Jan;38(1):115-21
– reference: 20510798 - J Am Coll Surg. 2010 Jun;210(6):901-8
– reference: 3928249 - Crit Care Med. 1985 Oct;13(10):818-29
– reference: 12395026 - Med Care. 2002 Oct;40(10):929-40
– reference: 22091571 - J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S262-8
– reference: 23067364 - BMC Med. 2012;10:120
– reference: 24088092 - N Engl J Med. 2013 Oct 3;369(14):1306-16
– reference: 21926598 - Crit Care Med. 2012 Jan;40(1):125-31
– reference: 16129869 - CMAJ. 2005 Aug 30;173(5):489-95
SSID ssj0000327
Score 2.5903306
Snippet Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes. We...
Background: Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserves that confers vulnerability to adverse outcomes....
Interpretation: Frailty was common among critically ill adults aged 50 and older and identified a population at increased risk of adverse events, morbidity and...
Results: The prevalence of frailty was 32.8% (95% confidence interval [CI] 28.3%-37.5%). Frail patients were older, were more likely to be female, and had more...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage E95
SubjectTerms Aged
Care and treatment
Cohort Studies
Critical Illness
Critically ill
Elder care
Female
Frail Elderly
Frailty
Humans
Intensive care
Male
Medical prognosis
Medical research
Medicine, Experimental
Patients
Prognosis
Prospective Studies
Quality of life
Severity of Illness Index
Studies
Time Factors
Title Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study
URI https://www.ncbi.nlm.nih.gov/pubmed/24277703
https://www.proquest.com/docview/1507563693
https://www.proquest.com/docview/1499126686
https://www.proquest.com/docview/1514417164
https://pubmed.ncbi.nlm.nih.gov/PMC3903764
Volume 186
WOSCitedRecordID wos000330267300016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: DOA
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Canadian Business & Current Affairs Database
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: 8FQ
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/cbcacomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (Proquest)
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: 7X7
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Healthcare Administration Database
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: M0T
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthmanagement
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: 7RV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: BENPR
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database (ProQuest)
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: M2M
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: M2O
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1488-2329
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000327
  issn: 0820-3946
  databaseCode: M2P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbYhhAv3C9hoxg0gYQULakTx-YFDbQKHlpKGahvUeI4XaWQdE2KtGf-OOc4btegaULi5aiSv7a2jn0u9rkQchhEXAceS10pfO0GKsjgSGXcjUKeC6HDVPLUNJuIRiMxncqxvXCrbVjlWiYaQZ1VCu_Ij9BwCTnjkr1fnLvYNQpfV20LjR2yB5aNjyFdw_74UhKztmWrwCxhGXCbnxd67Ej9TDDECxV0RyP9LZe3FFM3aHJLCw3u_u_875E71v6kx-2GuU9u6PIBuTW0L-wPye8tflEbxEXzZTIvmgualBmtz8Bgd83HoipnLop2Wq0amIWuqeldRJXtn1Bc0HlRUFu7tX5HE2oCGM3iNIUVrBM9KTbqXTbUVLt9RL4PTk4_fnJtowZXRUw2bg5WkOahAm3IhdQ8C1PB_EQJ3-fgkKS-Sn18782jhOVZzjKeSY9rqcG7y8AmYY_JblmV-imhIkyTPJVSgR8VgPssMi-Rsh9mUdbXXtJ3yNs1s2Jlq5hjM40iRm8GOBsjZ-OWsw453IAXbfGOq2EvkOtxm3m6OfLxMQPzLwCfjTvklUFgwYwSI3Jmyaqu48_fRv8CmnRAbywor2DeKrFZELB6LMTVQe53kGoxP4-3Rl93RmdtkfKrfuagAwTpobrD6-0aW-lVx5d71SEvN8P4TYzIK3W1Agy4yj5Yd4JfgwnRXUeP3CFP2tOz4QP8fRSBunFI1DlXGwDWPe-OlPMzU_-cSQ_UYvDs-qnvk9tg3AYmwj44ILvNcqWfk5vqVzOvlz2yE01-IJ1GhgqgYvC1R_Y-nIzGk565mwE69E6R9oeGfjF0_AdUfntN
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1ba9RAFB5qFfXF-yW22lGqghCaZCaTGUGkqKVL26Vohb7FZDLZLsRku8kq--z_8Td6Ti7bjZTiSx98C5wvt8m5Ts6FkE0eCMMdFttKusbmmicgUomwA1-kUho_ViKuh00Ew6E8PlaHK-R3VwuDaZWdTqwVdVJo3CPfQsfFF0wo9n5yauPUKPy72o3QaNhiz8x_QshWvht8hO_70vN2Ph192LXbqQK2Dpiq7BRMthG-BtUtpDIi8WPJ3EhL1xXgPceujl38OZkGEUuTlCUiUY4wykAokoABZXDdK-Qqx85imCroHZ5pftaMiJVYlay4aOsBfYdt6e8RppShQ9CzgH_bgSVD2E_SXLJ6O7f_t_W6Q261_jXdbgTiLlkx-T1y_aDNILhPfi3xI22T1Gg6jcZZNadRntDyBAISuz7Minxko-mixayCtzYlrWczUd3Oh8jmdJxltO1NW76lEa0TNOvFNBRWrCtkpTiIeFrRupvvA_L1UpbgIVnNi9w8JlT6cZTGSmmIEzljUiZOpJTnJ0HiGSfyLPKmY45Qt13acVhIFmK0BpwUIieFDSdZZHMBnjTNSc6HbSCXhU1l7UKlhdsM3FsOMamwyIsagQ1Bcsw4GkWzsgwHX4b_AvrcA71uQWkBz62jtsoD3h4bjfWQaz2knoxPwyXqqx511DRhP-8y6z0gaEfdJ3fiEbbauQzPZMMizxdkPBMzDnNTzADDIXIC71WKCzA-bkfgjoNFHjXSuvgOcPsgAHNqkaAnxwsA9nXvU_LxSd3fnSkHzD5_cvGjb5Abu0cH--H-YLi3Rm6CI8_ragK-Tlar6cw8Jdf0j2pcTp_VSoqSb5ct5X8ABWjNMA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+frailty+and+short-+and+long-term+outcomes+among+critically+ill+patients%3A+a+multicentre+prospective+cohort+study&rft.jtitle=Canadian+Medical+Association+journal+%28CMAJ%29&rft.au=Bagshaw%2C+Sean+M&rft.au=Stelfox%2C+H.+Thomas&rft.au=McDermid%2C+Robert+C&rft.au=Rolfson%2C+Darryl+B&rft.date=2014-02-04&rft.pub=Joule+Inc&rft.issn=0820-3946&rft.volume=186&rft.issue=2&rft.spage=E95&rft_id=info:doi/10.1503%2Fcmaj.130639&rft.externalDBID=ISN&rft.externalDocID=A361242176
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0820-3946&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0820-3946&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0820-3946&client=summon